Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
Most normal matter in the universe isn't found in planets, stars or galaxies – an astronomer explains where it's distributed - 2Which Switch Game Do You Suggest? Share Your Decision
- 3Turkiye’s Erdogan calls Israel’s Somaliland recognition ‘unacceptable’
- 4Finding the Force of Mentorship: Self-awareness Through Direction
- 5Best Amusement Park in Europe: Where Do You Very much want to Visit?
- From Representative to Business visionary: Private issue Victories
- Most loved Fish Dish: What's Your Sea Pleasure?
- Finding the Universe of Computer generated Reality: Individual Encounters
- The Best Business visionaries Under 30
- Vote in favor of the Top Vegetable for Senior
- This Unique National Park In Canada Is Famous For Its Otherworldly Limestone Monoliths
- Step by step instructions to Think about Disc Rates Across Various Banks
- Green Inflections: A Manual for Inside Plants
- Understanding the Rudiments of Tree Administrations
